Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.

Duarte-Rojo A, Veldt BJ, Goldstein DD, Tillman HL, Watt KD, Heimbach JK, McHutchison JG, Poterucha JJ, Vargas-Vorackova F, Charlton MR.

Transplantation. 2012 Jul 27;94(2):197-203. doi: 10.1097/TP.0b013e3182547551.

PMID:
22766768
2.

Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.

Lim KB, Sima HR, Fiel MI, Khaitova V, Doucette JT, Chernyiak M, Ahmad J, Bach N, Chang C, Grewal P, Kim-Schluger L, Liu L, Odin J, Perumalswami P, Florman SS, Schiano TD.

World J Gastroenterol. 2015 May 28;21(20):6236-45. doi: 10.3748/wjg.v21.i20.6236.

3.

Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation.

Coto-Llerena M, Pérez-Del-Pulgar S, Crespo G, Carrión JA, Martínez SM, Sánchez-Tapias JM, Martorell J, Navasa M, Forns X.

Am J Transplant. 2011 May;11(5):1051-7. doi: 10.1111/j.1600-6143.2011.03491.x. Epub 2011 Apr 5.

4.

Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy.

Eurich D, Boas-Knoop S, Bahra M, Neuhaus R, Somasundaram R, Neuhaus P, Neumann U, Seehofer D.

Transplantation. 2012 Mar 27;93(6):644-9. doi: 10.1097/TP.0b013e318244f774.

PMID:
22411462
5.

Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.

Mueller JL, King LY, Johnson KB, Gao T, Nephew LD, Kothari D, Simpson MA, Zheng H, Wei L, Corey KE, Misdraji J, Lee JH, Lin MV, Gogela NA, Fuchs BC, Tanabe KK, Gordon FD, Curry MP, Chung RT.

Clin Transplant. 2016 Apr;30(4):452-60. doi: 10.1111/ctr.12710. Epub 2016 Mar 1.

6.

Interleukin-28B polymorphism in hepatitis C and liver transplantation.

Duarte-Rojo A, Deneke MG, Charlton MR.

Liver Transpl. 2013 Jan;19(1):49-58. doi: 10.1002/lt.23554.

7.

Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.

Lange CM, Moradpour D, Doehring A, Lehr HA, Müllhaupt B, Bibert S, Bochud PY, Antonino AT, Pascual M, Farnik H, Shi Y, Bechstein WO, Moench C, Hansmann ML, Sarrazin C, Lötsch J, Zeuzem S, Hofmann WP.

J Hepatol. 2011 Aug;55(2):322-7. doi: 10.1016/j.jhep.2010.10.037. Epub 2010 Dec 13.

PMID:
21147186
8.

Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.

Cisneros E, Baños I, Citores MJ, Duca A, Salas C, Noblejas A, Cañizares M, Millán I, Cuervas-Mons V, Vilches C.

Transplantation. 2012 Aug 15;94(3):275-80.

PMID:
22790387
9.

CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.

Firpi RJ, Dong H, Clark VC, Soldevila-Pico C, Morelli G, Cabrera R, Norkina O, Shuster JJ, Nelson DR, Liu C.

Liver Int. 2013 Jan;33(1):72-8. doi: 10.1111/liv.12013. Epub 2012 Oct 29.

10.

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.

Sarrazin C, Susser S, Doehring A, Lange CM, Müller T, Schlecker C, Herrmann E, Lötsch J, Berg T.

J Hepatol. 2011 Mar;54(3):415-21. doi: 10.1016/j.jhep.2010.07.041. Epub 2010 Sep 22.

PMID:
21112657
11.

Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.

Biggins SW, Trotter J, Gralla J, Burton JR Jr, Bambha KM, Dodge J, Brocato M, Cheng L, McQueen M, Forman L, Chang M, Kam I, Everson G, Spritz RA, Klintmalm G, Rosen HR.

J Hepatol. 2013 May;58(5):969-76. doi: 10.1016/j.jhep.2012.12.027. Epub 2013 Jan 15.

12.

Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.

Ackefors M, Nyström J, Wernerson A, Gjertsen H, Sönnerborg A, Weiland O.

J Viral Hepat. 2013 Nov;20(11):770-8. doi: 10.1111/jvh.12099. Epub 2013 Apr 23.

PMID:
24168256
13.

Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantation.

Coto-Llerena M, Crespo G, González P, Koutsoudakis G, Miquel R, Navasa M, Forns X, Pérez-del-Pulgar S.

J Hepatol. 2012 Feb;56(2):355-8. doi: 10.1016/j.jhep.2011.07.027. Epub 2011 Sep 1.

PMID:
21889467
14.

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.

Charlton MR, Thompson A, Veldt BJ, Watt K, Tillmann H, Poterucha JJ, Heimbach JK, Goldstein D, McHutchison J.

Hepatology. 2011 Jan;53(1):317-24. doi: 10.1002/hep.24074.

15.

Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation.

Graziadei IW, Zoller HM, Schloegl A, Nachbaur K, Pfeiffer KP, Mark W, Mikuz G, Pratschke J, Margreiter R, Vogel W.

Liver Transpl. 2012 Jun;18(6):671-9. doi: 10.1002/lt.23402.

16.

Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation.

Crespo G, Carrión JA, Coto-Llerena M, Mariño Z, Lens S, Pérez-Del-Pulgar S, García-Retortillo M, Miquel R, Bosch J, Navasa M, Forns X.

J Gastroenterol. 2013 Jun;48(6):762-9. doi: 10.1007/s00535-012-0680-2. Epub 2012 Sep 26.

PMID:
23011083
17.

Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.

Tao R, Ruppert K, Cruz RJ Jr, Malik SM, Shaikh O, Ahmad J, DiMartini A, Humar A, Fontes PA, de Vera ME.

Liver Transpl. 2010 Nov;16(11):1288-95. doi: 10.1002/lt.22168.

18.

Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.

Veldt BJ, Duarte-Rojo A, Thompson AJ, Watt KD, Heimbach JK, Tillmann HL, Goldstein DD, McHutchison JG, Charlton MR.

Am J Transplant. 2012 Mar;12(3):737-44. doi: 10.1111/j.1600-6143.2011.03843.x. Epub 2012 Feb 2.

19.

The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation.

Allam SR, Krüger B, Mehrotra A, Schiano T, Schröppel B, Murphy B.

PLoS One. 2013;8(1):e54854. doi: 10.1371/journal.pone.0054854. Epub 2013 Jan 30.

20.

CC genotype at rs12979860 of IL28B is associated with lower risk of new-onset diabetes after transplantation in adult patients with liver transplantation for hepatitis C cirrhosis.

Duca AM, de la Fuente S, Citores MJ, Cuenca AB, Cisneros E, Escamilla N, Baños I, Vilches C, Cuervas-Mons V.

Transplant Proc. 2014 Nov;46(9):3114-6. doi: 10.1016/j.transproceed.2014.10.004.

PMID:
25420838

Supplemental Content

Support Center